Literature DB >> 11119594

Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants.

T M Cairns1, R C Craven.   

Abstract

The major structural protein of the retroviral core (CA) contains a conserved sequence motif shared with the CA-like proteins of distantly related transposable elements. The function of this major region of homology (MHR) has not been defined, in part due to the baffling array of phenotypes in mutants of several viruses and the yeast TY3. This report describes new mutations in the CA protein of Rous sarcoma virus (RSV) that were designed to test whether these different phenotypes might indicate distinct functional subdomains in the MHR. A comparison of 25 substitutions at 10 positions in the RSV conserved motif argues against this possibility. Most of the replacements destroyed virus infectivity, although either of two lethal phenotypes was obtained depending on the residue introduced. At most of the positions, one or more replacements (generally the more conservative substitutions) caused a severe replication defect without having any obvious effects on virus assembly, budding, Gag-Pol and genome incorporation, or protein processing. The mutant particles exhibited a defect in endogenous viral DNA synthesis and showed increased sensitivity of the core proteins to detergent, indicating that the mutations interfere with the formation and/or activity of the virion core. The distribution of these mutations across the MHR, with no evidence of clustering, suggests that the entire region is important for a critical postbudding function. In contrast, a second class of lethal substitutions (those that destroyed virus assembly and release) consists of alterations that are expected to cause severe effects on protein structure by disruption either of the hydrophobic core of the CA carboxyl-terminal domain or of the hydrogen bond network that stabilizes the domain. We suggest that this duality of phenotypes is consistent with a role for the MHR in the maturation process that links the two parts of the life cycle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119594      PMCID: PMC113918          DOI: 10.1128/JVI.75.1.242-250.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Structure and self-association of the Rous sarcoma virus capsid protein.

Authors:  R L Kingston; T Fitzon-Ostendorp; E Z Eisenmesser; G W Schatz; V M Vogt; C B Post; M G Rossmann
Journal:  Structure       Date:  2000-06-15       Impact factor: 5.006

3.  A nucleoprotein complex mediates the integration of retroviral DNA.

Authors:  B Bowerman; P O Brown; J M Bishop; H E Varmus
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

4.  Properties of a ribonucleoprotein particle isolated from Nonidet P-40-treated Rous sarcoma virus.

Authors:  N L Davis; R R Rueckert
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

5.  Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures.

Authors:  D P Bolognesi; R Luftig; J H Shaper
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

7.  Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses.

Authors:  R Campos-Olivas; J L Newman; M F Summers
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

8.  Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail.

Authors:  C Moscovici; M G Moscovici; H Jimenez; M M Lai; M J Hayman; P K Vogt
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

9.  Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Stromberg; N E Hurley; N L Davis; R R Rueckert; E Fleissner
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

10.  Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus.

Authors:  P Jolicoeur; E Rassart
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

View more
  34 in total

1.  Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions.

Authors:  J B Bowzard; J W Wills; R C Craven
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Element-specific localization of Drosophila retrotransposon Gag proteins occurs in both nucleus and cytoplasm.

Authors:  S Rashkova; S E Karam; M-L Pardue
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

4.  A long terminal repeat-containing retrotransposon of Schizosaccharomyces pombe expresses a Gag-like protein that assembles into virus-like particles which mediate reverse transcription.

Authors:  Laure Teysset; Van-Dinh Dang; Min Kyung Kim; Henry L Levin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study.

Authors:  Carmen Butan; Parvez M Lokhandwala; John G Purdy; Giovanni Cardone; Rebecca C Craven; Alasdair C Steven
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

7.  Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography.

Authors:  Jordan Benjamin; Barbie K Ganser-Pornillos; William F Tivol; Wesley I Sundquist; Grant J Jensen
Journal:  J Mol Biol       Date:  2004-12-19       Impact factor: 5.469

8.  Ty3 capsid mutations reveal early and late functions of the amino-terminal domain.

Authors:  Liza S Z Larsen; Min Zhang; Nadejda Beliakova-Bethell; Virginia Bilanchone; Anne Lamsa; Kunio Nagashima; Rani Najdi; Kathryn Kosaka; Vuk Kovacevic; Jianlin Cheng; Pierre Baldi; G Wesley Hatfield; Suzanne Sandmeyer
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

9.  RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis.

Authors:  Carmen Butan; Dennis C Winkler; J Bernard Heymann; Rebecca C Craven; Alasdair C Steven
Journal:  J Mol Biol       Date:  2007-12-08       Impact factor: 5.469

10.  A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.

Authors:  Sook-Kyung Lee; Janera Harris; Ronald Swanstrom
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.